ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2017, Volume 68, Issue 12, 3022-3026

https://doi.org/10.37358/RC.17.12.6030

Cristina Talpos, Luminita Ageu, Simina Crisan, Carmen Lacramioara Zamfir, Vladimir Poroch, Mirela Anghel

Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment

Abstract:

We approach an integrated, multidisciplinary, innovative research-action model in children and adolescents with psychosis. Our main focus was: to investigate the biochemical cerebral compounds and metabolites (NAA-N-acetylaspartate, GABA-Gama-Aminobutyric Acid, Asp-Aspartate, CR-Creatine, Gln-Glutamine, GPC-Glicerophosphocholine, PC-Phosphocholine, PCr-Phosphocreatine, Tau-Taurine, N-MDA-N-Metyl-D-Aspartate, Serine, Glicine, Cho-Choline); the neuroimagistic and neurobiological markers and the metabolic abnormalities in correlation with the molecular pharmacogenetic testing in psychoses, treated with antipsychotic medication; the dynamic evaluation of the clinical evolution for the studied groups in correlation with specific biochemical, metabolic, neurobiological and neuroimagistic variables and markers. Our research was conducted in the period 2010-2016 on 85 patients, children and adolescents with psychosis (42 took treatment after pharmacogenetic testing, 43 without). Also, the patients were evaluated through magnetic resonance (MR) spectroscopy at baseline and after pharmacotherapy. The efficacy of the chosen therapy in correlation with the pharmacogenetic testing was evaluated through the mean change in the Positive and Negative Syndrome Scale (PANSS) total scores, in the Clinical Global Impression Severity (CGI-S/I), Clinical Global Assessment of Functioning (CGAS) and through the change registered for the relevant biochemical, metabolic, neurobiological markers and MR spectroscopy metabolites, from baseline till endpoint in different timepoints. Our results, showed statistically significant differences of the clinical scores between the studied groups. Our research was a proof, that the biochemical brain metabolites register in psychoses modified values in the MR Spectroscopy, the administration of antipsychotics can determine metabolic abnormalities (changed lipid profiles, high insulin and blood sugar levels, weight gain, obesity). But on the other side, if the antipsychotic treatment is chosen properly according to the pharmacogenetic profile of the patient, then the biochemical metabolites obtained through the MR Spectroscopy, register improvement of the values correlated with the good clinical evolution.
Keywords:
biochemical metabolites; metabolic abnormalities; antipsychotics; NAA-N-acetylaspartate; GABA-Gama-Aminobutyric Acid; N-MDA

Issue: 2017, Volume 68, Issue 12
Pages: 3022-3026
Publication date: 2018/1/15
https://doi.org/10.37358/RC.17.12.6030
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
Citation Styles
Cite this article as:
TALPOS, C., AGEU, L., CRISAN, S., ZAMFIR, C.L., POROCH, V., ANGHEL, M., Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment, Rev. Chim., 68(12), 2017, 3022-3026.

Vancouver
Talpos C, Ageu L, Crisan S, Zamfir CL, Poroch V, Anghel M. Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment. Rev. Chim.[internet]. 2017 Dec;68(12):3022-3026. Available from: https://doi.org/10.37358/RC.17.12.6030


APA 6th edition
Talpos, C., Ageu, L., Crisan, S., Zamfir, C.L., Poroch, V. & Anghel, M. (2017). Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment. Revista de Chimie, 68(12), 3022-3026. https://doi.org/10.37358/RC.17.12.6030


Harvard
Talpos, C., Ageu, L., Crisan, S., Zamfir, C.L., Poroch, V., Anghel, M. (2017). 'Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment', Revista de Chimie, 68(12), pp. 3022-3026. https://doi.org/10.37358/RC.17.12.6030


IEEE
C. Talpos, L. Ageu, S. Crisan, C.L. Zamfir, V. Poroch, M. Anghel, "Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment". Revista de Chimie, vol. 68, no. 12, pp. 3022-3026, 2017. [online]. https://doi.org/10.37358/RC.17.12.6030


Text
Cristina Talpos, Luminita Ageu, Simina Crisan, Carmen Lacramioara Zamfir, Vladimir Poroch, Mirela Anghel,
Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment,
Revista de Chimie,
Volume 68, Issue 12,
2017,
Pages 3022-3026,
ISSN 2668-8212,
https://doi.org/10.37358/RC.17.12.6030.
(https://revistadechimie.ro/Articles.asp?ID=6030)
Keywords: biochemical metabolites; metabolic abnormalities; antipsychotics; NAA-N-acetylaspartate; GABA-Gama-Aminobutyric Acid; N-MDA


RIS
TY - JOUR
T1 - Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment
A1 - Talpos, Cristina
A2 - Ageu, Luminita
A3 - Crisan, Simina
A4 - Zamfir, Carmen Lacramioara
A5 - Poroch, Vladimir
A6 - Anghel, Mirela
JF - Revista de Chimie
JO - Rev. Chim.
PB - Revista de Chimie SRL
SN - 2668-8212
Y1 - 2017
VL - 68
IS - 12
SP - 3022
EP - 3026
UR - https://doi.org/10.37358/RC.17.12.6030
KW - biochemical metabolites
KW - metabolic abnormalities
KW - antipsychotics
KW - NAA-N-acetylaspartate
KW - GABA-Gama-Aminobutyric Acid
KW - N-MDA
ER -


BibTex
@article{RevCh2017P3022,
author = {Talpos Cristina and Ageu Luminita and Crisan Simina and Zamfir Carmen Lacramioara and Poroch Vladimir and Anghel Mirela},
title = {Metabolic Abnormalities and Spectroscopy Biochemical Cerebral Compounds Modifications in Children and Adolescents with Antipsychotic Treatment},
journal = {Revista de Chimie},
volume = {68},
number = {12},
pages = {3022-3026},
year = {2017},
issn = {2668-8212},
doi = {https://doi.org/10.37358/RC.17.12.6030},
url = {https://revistadechimie.ro/Articles.asp?ID=6030}
}
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice